Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chemical luminescence reagent kit for detecting herpes simplex virus type II IgM antibody

A technology of herpes simplex virus and chemiluminescent reagents, applied in the field of immunoassay medicine, can solve the problems of insufficient objectivity, endogenous enzyme interference, carcinogens, etc.

Inactive Publication Date: 2009-02-18
CHEMCLIN DIAGNOSTICS CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although radioimmunoassay is highly sensitive and specific, it has the disadvantages of short validity period and radioactive contamination
Although the fluorescent immunoassay method has strong specificity, high sensitivity and fast speed, the problem of non-specific staining has not been completely solved, the objectivity of the result judgment is not enough, and the procedure is relatively complicated
Although enzyme-linked immunoassay has high sensitivity and specificity, it has disadvantages such as endogenous enzyme interference, most of the substrates are toxic or carcinogenic, and external factors such as scratches will also affect the determination of absorbance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chemical luminescence reagent kit for detecting herpes simplex virus type II IgM antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Preparation of chemiluminescence kit for herpes simplex virus type II IgM antibody:

[0030] Negative control substance: HSV-II IgM negative human serum was inactivated at 56°C for 1 hour, sterilized and filtered, and stored at 2-8°C.

[0031] Positive control substance: confirmed high-titer HSV-II IgM positive human serum, inactivated at 56°C for 1 hour, buffered with 0.02mol / LTris-HCl containing 10% newborn bovine serum, 0.1% preservative, pH7.2 The positive control substance was prepared after dilution with the solution, the dilution ratio was 1:200, and stored at 2-8°C.

[0032] Preparation of enzyme-labeled herpes simplex virus type II antibody: the herpes simplex virus type II antibody was coupled with alkaline phosphatase by the glutaraldehyde method, fully dialyzed against 0.01mol / L pH7.4 phosphate buffer, and added an equal volume of glycerol , Store below -20°C for later use. Weigh 12.120g of Tris, 10mL of HCl, 5g of bovine serum albumin (BSA), 1mL of procli...

Embodiment 2

[0038] Herpes simplex virus type II IgM antibody chemiluminescence immunoassay assay kit

[0039] Except that the plastic tube was used as the solid phase carrier, the rest were prepared in the same manner as in Example 1 to prepare a chemiluminescence immunoassay kit for the herpes simplex virus type II IgM antibody.

Embodiment 3

[0041] Preparation of chemiluminescent immunoassay kit for herpes simplex virus type II IgM antibody:

[0042] Preparation of enzyme-labeled herpes simplex virus type II antibody: Dilute the enzyme-labeled antibody with enzyme-labeled diluent, and select the dilution of enzyme-labeled antibody as 1:5000.

[0043] Preparation of neutralizing antigen: select the dilution of neutralizing antigen as 1:4500.

[0044] All the other are identical with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a chemiluminescence immunoassay test kit and a preparing method thereof for detecting herpes simplex virus type II IgG antibody. The technical principle that the test kit adopts the capture method to detect herpes simplex virus type II IgG antibody is that: antihuman u link monoclonal antibody is absorbed into solid-phase carrier, and sample to be tested is added in, and then specific antigen and enzyme labeled antibody are added in after washing so as to form immune complex, finally chemiluminescence zymolyte liquid is added in, and the content of the IgM antibody can be obtained through measuring the chemiluminescence value. The enzyme is alkaline phosphatase, and the chemiluminescence zymolyte liquid contains 1,2-butyl dioxide derivatives. The test kit has the advantages that the operation is simple, the precision is better, the sample detecting result conforms the detecting result by the enzyme linked immunity analysis method.

Description

technical field [0001] The invention relates to the field of immunoanalysis medicine, in particular to a chemiluminescence kit for detecting herpes simplex virus type II IgM antibody and a preparation method thereof. Background technique [0002] Herpes simplex virus (HSV) is round in shape, the inner layer is a core composed of double-stranded linear DNA, and the outer layer is a three-layer shell structure. There are two serotypes of HSV, HSV-I infection accounts for 10%, often oral mucosa, upper body skin, lymph node enlargement, mainly causes upper body skin, mucous membrane or organ herpes, but rarely infects the fetus. HSV-II type is genital herpes, accounting for 90%, mainly causing genital herpes, anus and skin herpes below the waist, and direct sexual transmission accounts for the vast majority. The symptoms of HSV infection in pregnant women are mainly herpes, ulcers and pain in the cervix, vagina and external genitalia. The symptoms of neonatal infection in the b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/577G01N33/571G01N21/76G01N33/535
Inventor 蒋冰飞应希堂宋胜利胡国茂郑金来于尚永
Owner CHEMCLIN DIAGNOSTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products